Mild to moderate Alzheimer dementia with insufficient neuropathological changes. - Wikidata - awgldk - TriplyDB

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

http://www.wikidata.org/entity/Q33592693

about

Immune and myodegenerative pathomechanisms in inclusion body myositis Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle.Primary age-related tauopathy (PART): a common pathology associated with human aging Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease APOEε2 is associated with milder clinical and pathological Alzheimer disease.Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathology Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role.Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design.Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.Staging Alzheimer's Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease.The effect of Scutellaria baicalensis stem-leaf flavonoids on spatial learning and memory in chronic cerebral ischemia-induced vascular dementia of rats.Of Energy and Entropy: The Ineluctable Impact of Aging in Old Age Dementia.Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.Effectiveness of Florbetapir PET Imaging in Changing Patient Management.CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Failure analysis of clinical trials to test the amyloid hypothesis.Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease Alzheimer dementia with sparse amyloid—AD mimic or variant?

P2860

Q33753870-7B71475F-97E0-4BED-B059-DEBC447A79C4 Q33817811-22BF209F-225D-4542-ABF6-BA2A36A71E2B Q34445021-FFDFA881-370D-4DF8-B06A-9DCBD8906E4B Q35195654-99BE0FFB-AB79-4B19-AC06-2685D70FA23F Q35660968-514D5A3B-79D0-48B5-8DC6-98D0FD085F92 Q35669877-4732D34D-3BD9-48E3-870B-72C31A127681 Q35896890-4A771398-3A81-4057-82C5-10D6F1532D58 Q36270381-2ABE4EC3-B6D9-4C1A-A261-8E60DF0AF88F Q36560884-13B69B10-8437-4816-B229-3A9DD7427AB8 Q36801792-98808585-E45B-4748-8277-CF7A35DB3BF3 Q36813196-41FAA317-9830-4308-A17E-61287AAED044 Q38904336-E585A835-4440-46A0-A7F8-AAC7B129DB96 Q38911065-279C7B50-56A9-4431-906A-B71291C746FF Q39644582-ECE62313-7120-47A8-B049-64FF695941CB Q41370810-02E92CB7-3613-4A23-99B2-B8412E0CEA53 Q41467128-68DAA5A5-3D13-4276-806F-9889CED6985D Q41884186-232EAE46-CF11-4674-9A6D-07331E2CA73C Q46713723-2533139B-7ED3-4FB7-BDB5-594C16BDF5E2 Q50206737-0A66B27B-AD78-405C-BDCF-93405E984BCB Q50348918-547294A2-54DE-4C64-8AEB-14F2D80E191A Q50533084-9510E26E-B8E2-4E40-B308-F7247471207F Q52589491-E30D9BF6-3405-4057-B578-1E6F09005A22 Q53354937-BAC4358D-430E-4363-8BEF-ADD121D26135 Q57800439-9E28D4BA-E173-4470-98C0-5DB6342BFB62 Q58035805-DB2E7183-5900-47A2-8120-4F7F60CFBB85

P2860

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

http://www.wikidata.org/entity/Q33592693

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

@ast

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

@en

type

label

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

@ast

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

@en

prefLabel

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

@ast

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

@en

P1433

Q33592693-AF5A64B5-6B99-4581-9C0D-7E0824E0F532

P1476

Q33592693-AE96531B-4A0B-4D20-B4BD-F599B2A8E393

P2093

Q33592693-02385168-965E-49FF-98F1-2478F9B266AA

Q33592693-534C809F-1050-4A37-8AA1-F1BA151EBCD5

Q33592693-875E6F8E-30F7-4E90-9597-917295A977FB

Q33592693-8E3E05DC-90FB-4895-8106-CF48987052AB

Q33592693-A06CBF93-456F-4E6E-A593-6EFE42185E3D

Q33592693-D899D2AF-11BC-4503-AE59-666AD760D9D3

Q33592693-D9C3FCDC-EC1C-4920-A396-C07A52CB75AE

Q33592693-DC3623B8-F965-490C-BE31-69A118434C60

P2860

Q33592693-075C1993-C535-4D7C-B397-F925DFA8F779

Q33592693-1234BDF0-FB36-459D-9FE9-29B6D91DCB80

Q33592693-19E8A1F5-0835-400D-B04D-2E29DFAD6368

Q33592693-26BFF7AA-11A2-4EA3-BFD0-868CB582E73B

Q33592693-29C4B469-4DF5-4922-A65F-D93B439D593A

Q33592693-2BBB9F46-F707-4EBD-9D54-50D00321A035

Q33592693-3F322B65-4202-4ACB-96F6-5B447197B929

Q33592693-4921070F-F1A4-44B4-923A-A43E6727CAC2

Q33592693-61C5EA27-F2C5-4B7C-8968-ECD57E26B88D

Q33592693-6E702AC0-470C-407B-83B1-94D94023EEBB

P304

Q33592693-565042F9-63D8-4179-A10D-D66500B17A75

P31

Q33592693-AD09134B-4389-4AD6-AE48-5C0721C482B6

P356

Q33592693-55E82832-E5CB-44D5-A6A0-48EE2D13A2DA

P433

Q33592693-B6CD81D8-6D31-48EB-98DD-0E531B2BE94E

P478

Q33592693-E660F508-9255-43F6-8D42-08FDE10C912F

P50

Q33592693-32F70930-6782-44A5-B5F7-68FDA5987952

Q33592693-512D277F-3B4B-4B63-9A7A-FDC5DB423270

Q33592693-8757853C-0036-46F1-B444-C94AB3F0C567

P577

Q33592693-F88F6F3D-8EAE-4969-8934-332E81DA08A5

P5875

Q33592693-EE4D8CFD-339B-4302-810F-703ADC3A5083

P698

Q33592693-6C84F9EE-6FE1-4144-B161-E1248B7CFFA8

P921

Q33592693-4E12FBEA-B05A-4D45-A687-7C956910FDB1

Q33592693-C46566BA-EA6A-4E65-B390-AF9DDFBFD757

P932

Q33592693-3EECEAE1-CB7F-4EC2-9CA5-38C93AE59641

P356

P1433

Annals of Neurology

P1476

Mild to moderate Alzheimer dementia with insufficient neuropathological changes.

@en

P2093

Jing Qian

http://www.w3.org/2001/XMLSchema#string

John H Growdon

http://www.w3.org/2001/XMLSchema#string

Keith A Johnson

http://www.w3.org/2001/XMLSchema#string

Matthew P Frosch

http://www.w3.org/2001/XMLSchema#string

Rebecca A Betensky

http://www.w3.org/2001/XMLSchema#string

Reisa A Sperling

http://www.w3.org/2001/XMLSchema#string

Sarah E Monsell

http://www.w3.org/2001/XMLSchema#string

Teresa Gómez-Isla

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathological stageing of Alzheimer-related changes

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.

The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.

Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics.

P304

597-601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24125

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

ALBERTO SERRANO-POZO

Deborah Blacker

P577

2014-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260446705

http://www.w3.org/2001/XMLSchema#string

P698

24585367

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4016558

http://www.w3.org/2001/XMLSchema#string